{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["2019-nCoV", "Coronaviruses", "Natural products", "SARS-CoV-2"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": [], "GeneralNote": [], "PMID": "33052305", "DateRevised": {"Year": "2023", "Month": "11", "Day": "12"}, "Article": {"ArticleDate": [{"Year": "2020", "Month": "10", "Day": "08"}], "Language": ["eng"], "ELocationID": ["10.1016/j.cpb.2020.100180"], "Journal": {"ISSN": "2214-6628", "JournalIssue": {"Volume": "24", "PubDate": {"Year": "2020", "Month": "Dec"}}, "Title": "Current plant biology", "ISOAbbreviation": "Curr Plant Biol"}, "ArticleTitle": "Challenges and future directions of potential natural products leads against 2019-nCoV outbreak.", "Pagination": {"StartPage": "100180", "MedlinePgn": "100180"}, "Abstract": {"AbstractText": ["Except for Remdesivir\u00ae no other drug or vaccine has yet been approved to treat the coronavirus disease (COVID-19) caused by the virus known as, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Remdesivir\u00ae an small molecule and nucleic acid analogue, it is used to treat adults and children with laboratory confirmed COVID-19, only administrated in hospital settings. Small molecules and particularly natural products count for almost fifty percent of the commercially available drugs, several of them are marketed antiviral agents and those can be a potential agent to treat COVID-19 infections. This short review rationalized different key natural products with known activity against coronaviruses as potential leads against COVID-19."], "CopyrightInformation": "\u00a9 2020 The Authors."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "National Center for Natural Products Research, School of Pharmacy, University of Mississippi, University, MS, 38677, USA."}, {"Identifier": [], "Affiliation": "The Research Center for Medicinal Plants, Al-Farabi Kazakh National University, Al-Farabi ave. 71, 050040, Almaty, Kazakhstan."}], "LastName": "Ospanov", "ForeName": "Meirambek", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Drug Discovery and Biomedical Sciences, College of Pharmacy, University of South Carolina, Columbia, SC, 29208, USA."}], "LastName": "Le\u00f3n", "ForeName": "Francisco", "Initials": "F"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "The Research Center for Medicinal Plants, Al-Farabi Kazakh National University, Al-Farabi ave. 71, 050040, Almaty, Kazakhstan."}], "LastName": "Jenis", "ForeName": "Janar", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "National Center for Natural Products Research, School of Pharmacy, University of Mississippi, University, MS, 38677, USA."}], "LastName": "Khan", "ForeName": "IKhlas A", "Initials": "IA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "National Center for Natural Products Research, School of Pharmacy, University of Mississippi, University, MS, 38677, USA."}, {"Identifier": [], "Affiliation": "Chemistry of Natural Compounds Department, Pharmaceutical and Drug Industries Research Division, National Research Centre, Dokki, 12622, Cairo, Egypt."}], "LastName": "Ibrahim", "ForeName": "Mohamed A", "Initials": "MA"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Netherlands", "MedlineTA": "Curr Plant Biol", "NlmUniqueID": "101668942", "ISSNLinking": "2214-6628"}, "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Fehr A.R., Perlman S. Coronaviruses: an overview of their replication and pathogenesis. In: Maier H., Bickerton E., Britton P., editors. Coronaviruses. Methods in Molecular Biology. 2015. p. 1282.", "ArticleIdList": ["10.1007/978-1-4939-2438-7_1", "PMC4369385", "25720466"]}, {"Citation": "Payne S. 2017. Family Coronaviridae. Viruses; pp. 149\u2013158.", "ArticleIdList": ["10.1016/B978-0-12-803109-4.00017-9"]}, {"Citation": "Myint S.H. Human coronaviruses: a brief review. Rev. Med. Virol. 1994;4(1):35\u201346. doi: 10.1002/rmv.1980040108.", "ArticleIdList": ["10.1002/rmv.1980040108"]}, {"Citation": "Liang P.H. Characterization and inhibition of SARS-coronavirus main protease. Curr. Top. Med. Chem. 2006;6(4):361\u2013376. doi: 10.2174/156802606776287090.", "ArticleIdList": ["10.2174/156802606776287090", "16611148"]}, {"Citation": "Rachel L.G., Ralph S.B. Recombination, reservoirs, and the modular spike, mechanisms of coronavirus cross-species transmission. J. Virol. 2010;84(7):3134\u20133146. doi: 10.1128/jvi.01394-09.", "ArticleIdList": ["10.1128/jvi.01394-09", "PMC2838128", "19906932"]}, {"Citation": "Yi Y. COVID-19: what has been learned and to be learned about the novel coronavirus disease. Int. J. Biol. Sci. 2020;16(10):1753\u20131766. doi: 10.7150/ijbs.45134.", "ArticleIdList": ["10.7150/ijbs.45134", "PMC7098028", "32226295"]}, {"Citation": "van der Hoek L. Identification of a new human coronavirus. Nat. Med. 2004;10:368\u2013373. doi: 10.1038/nm1024.", "ArticleIdList": ["10.1038/nm1024", "PMC7095789", "15034574"]}, {"Citation": "Gralinski L.E., Menachery V.D. Return of the coronavirus: 2019-nCoV return of the coronavirus: 2019-nCoV. Viruses. 2020;12:135. doi: 10.3390/v12020135.", "ArticleIdList": ["10.3390/v12020135", "PMC7077245", "31991541"]}, {"Citation": "de Wit E. SARS and MERS: recent insights into emerging coronaviruses. Nat. Rev. Microbiol. 2016;14(8):523\u2013534. doi: 10.1038/nrmicro.2016.81.", "ArticleIdList": ["10.1038/nrmicro.2016.81", "PMC7097822", "27344959"]}, {"Citation": "https://www.fda.gov/drugs/drug-safety-and-availability/fda-cautions-against-use-hydroxychloroquine-or-chloroquine-covid-19-outside-hospital-setting-or#:\u223c:text=FDA%20cautions%20against%20use%20of%20hydroxychloroquine%20or%20chloroquine,treat%20hospitalized%20patients%20with%20COVID-19%20is%20now%20available, accessed on 09/27/2020."}, {"Citation": "https://coronavirus.jhu.edu/us-map, accessed on 07/13/2020."}, {"Citation": "Pruijssers A.J., Denison M.R. Nucleoside analogues for the treatment of coronavirus infections. Curr. Opin. Virol. 2019;35:57\u201362. doi: 10.1016/j.coviro.2019.04.002.", "ArticleIdList": ["10.1016/j.coviro.2019.04.002", "PMC7102703", "31125806"]}, {"Citation": "Haagmans B.L., Osterhaus D.M. Coronaviruses and their therapy. Antiviral Res. 2006;71:397\u2013403. doi: 10.1016/j.antiviral.2006.05.019.", "ArticleIdList": ["10.1016/j.antiviral.2006.05.019", "PMC7114240", "16837072"]}, {"Citation": "Li G., De Clercq E. Therapeutic options for the 2019 novel coronavirus (2019-nCoV) Nat. Rev., Drug Discover. 2020;19:149\u2013150. doi: 10.1038/d41573-020-00016-0.", "ArticleIdList": ["10.1038/d41573-020-00016-0", "32127666"]}, {"Citation": "Yin W. Structural basis for inhibition of the RNA-dependent RNA polymerase from SARS-CoV-2 by Remdesivir. Science. 2020;368(6498):1499\u20131504. doi: 10.1126/science.abc1560.", "ArticleIdList": ["10.1126/science.abc1560", "PMC7199908", "32358203"]}, {"Citation": "Yeming W. Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial. Lancet. 2020;395:1569\u20131578. doi: 10.1016/S0140-6736(20)31022-31029.", "ArticleIdList": ["10.1016/S0140-6736(20)31022-31029", "PMC7190303", "32423584"]}, {"Citation": "Kim D.E. Natural bis-benzylisoquinoline alkaloids-tetrandrine, fangchinoline, and cepharanthine, inhibit human coronavirus OC43 infection of MRC-5 human lung cells. Biomolecules. 2019;9(11):696. doi: 10.3390/biom9110696.", "ArticleIdList": ["10.3390/biom9110696", "PMC6921063", "31690059"]}, {"Citation": "Meng X.L. Bisbenzylisoquinoline alkaloids of lotus (Nelumbo nucifera Gaertn.) seed embryo inhibit lipopolysaccharide-induced macrophage activation via suppression of Ca2+-CaM/CaMKII pathway. Food Agric. Immunol. 2019;30(1):878\u2013896. doi: 10.1080/09540105.2019.1638889.", "ArticleIdList": ["10.1080/09540105.2019.1638889"]}, {"Citation": "Yang Y. Traditional Chinese medicine in the treatment of patients infected with 2019-New coronavirus (SARS-CoV-2): a review and perspective. Int. J. Biol. Sci. 2020;16(10):1708\u20131717. doi: 10.7150/ijbs.45538.", "ArticleIdList": ["10.7150/ijbs.45538", "PMC7098036", "32226288"]}, {"Citation": "Yang S. The status of Chinese medicine in reversing multi-drug resistance of hepatocellular carcinoma. Chin. -Ger. J. Clin. Oncol. 2011;10:541. doi: 10.1007/s10330-011-0828-1.", "ArticleIdList": ["10.1007/s10330-011-0828-1"]}, {"Citation": "Huang Yi-Tsau, Hong Chuang-Ye. Tetrandrine. Cardiovasc. Drug Rev. 1998;16(1):1\u201315. doi: 10.1111/j.1527-3466.1998.tb00341.x.", "ArticleIdList": ["10.1111/j.1527-3466.1998.tb00341.x"]}, {"Citation": "Tian F., Ding D., Li D. Fangchinoline targets PI3K and suppresses PI3K/AKT signaling pathway in SGC7901 cells. Int. J. Oncol. 2015;46:2355\u20132363. doi: 10.3892/ijo.2015.2959.", "ArticleIdList": ["10.3892/ijo.2015.2959", "PMC4441295", "25872479"]}, {"Citation": "Cinatl J. W. Treatment of SARS with human interferons. Lancet. 2003;362:293\u2013294. doi: 10.1016/S0140-6736(03)13973-6.", "ArticleIdList": ["10.1016/S0140-6736(03)13973-6", "PMC7112413", "12892961"]}, {"Citation": "Kretzing S. Dose-dependent emetic effects of the Amaryllidaceous alkaloid lycorine in beagle dogs. Toxicon. 2011;57:117\u2013124. doi: 10.1016/j.toxicon.2010.10.012.", "ArticleIdList": ["10.1016/j.toxicon.2010.10.012", "21055413"]}, {"Citation": "Li S.Y. Identification of natural compounds with antiviral activities against SARS-associated coronavirus. Antiviral Res. 2005;67:18\u201323. doi: 10.1016/j.antiviral.2005.02.007.", "ArticleIdList": ["10.1016/j.antiviral.2005.02.007", "PMC7114104", "15885816"]}, {"Citation": "Lin Ch.W. Anti-SARS coronavirus 3C-like protease effects of Isatis indigotica root and plant-derived phenolic compounds. Antiviral Res. 2005;68:36\u201342. doi: 10.1016/j.antiviral.2005.07.002.", "ArticleIdList": ["10.1016/j.antiviral.2005.07.002", "PMC7114321", "16115693"]}, {"Citation": "Mazumder A. Sinigrin and its therapeutic benefits. Molecules. 2016;21(4):416. doi: 10.3390/molecules21040416.", "ArticleIdList": ["10.3390/molecules21040416", "PMC6273501", "27043505"]}, {"Citation": "Chafekar A., Fielding B.C. MERS-CoV: understanding the latest human coronavirus threat. Viruses. 2018;10(2):93. doi: 10.3390/v10020093.", "ArticleIdList": ["10.3390/v10020093", "PMC5850400", "29495250"]}, {"Citation": "Docherty J.J. Resveratrol inhibition of herpes simplex virus replication. Antiviral Res. 1999;43(3):145\u2013155. doi: 10.1016/s0166-3542(99)00042-x.", "ArticleIdList": ["10.1016/s0166-3542(99)00042-x", "10551373"]}, {"Citation": "Neves A.R. Resveratrol in medicinal chemistry: a critical review of its pharmacokinetics, drug-delivery, and membrane interactions. Curr. Med. Chem. 2012;19:1663\u20131681. doi: 10.2174/092986712799945085.", "ArticleIdList": ["10.2174/092986712799945085", "22257059"]}, {"Citation": "Fr\u00e9mont L. Biological effects of resveratrol. Life Sci. 2000;66(8):663\u2013673. doi: 10.1016/S0024-3205(99)00410-5.", "ArticleIdList": ["10.1016/S0024-3205(99)00410-5", "10680575"]}, {"Citation": "Henning S.M. Variability in the antioxidant activity of dietary supplements from pomegranate, milk thistle, green tea, grape seed, goji, and acai: effects of in vitro digestion. J. Agric. Food Chem. 2014;62:4313\u20134332. doi: 10.1021/jf500106r.", "ArticleIdList": ["10.1021/jf500106r", "24745654"]}, {"Citation": "Weston L.A. Review of the biology and ecology of three invasive perennials in New York state: japanese knotweed (Polygonum cuspidatum), mugwort (Artemisia vulgaris) and pale swallow-wort (Vincetoxicum rossicum) Plant Soil. 2005;277:53\u201369. doi: 10.1007/s11104-005-3102-x.", "ArticleIdList": ["10.1007/s11104-005-3102-x"]}, {"Citation": "Timmers S. Calorie restriction-like effects of 30 days of resveratrol supplementation on energy metabolism and metabolic profile in obese humans. Cell Metab. 2011;14:612\u2013622. doi: 10.1016/j.cmet.2011.10.002.", "ArticleIdList": ["10.1016/j.cmet.2011.10.002", "PMC3880862", "22055504"]}, {"Citation": "Lin Y.M. Antiviral activities of biflavonoids. Planta Med. 1999;65:120\u2013125. doi: 10.1055/s-1999-13971.", "ArticleIdList": ["10.1055/s-1999-13971", "10193201"]}, {"Citation": "Ma Shuang-Cheng. Antiviral Amentoflavone from Selaginella sinensis. Biol. Pharm. Bull. 2001;24(3):311\u2013312. doi: 10.1248/bpb.24.311.", "ArticleIdList": ["10.1248/bpb.24.311", "11256492"]}, {"Citation": "Ryu Y.B. Biflavonoids from Torreya nucifera displaying SARS\u2010CoV 3CL (pro) inhibition. Bioorg. Med Chem. 2010;18:7940\u20137947. doi: 10.1016/j.bmc.2010.09.035.", "ArticleIdList": ["10.1016/j.bmc.2010.09.035", "PMC7126309", "20934345"]}, {"Citation": "Lee Eunjung. Cytotoxic activities of amentoflavone against human breast and cervical cancers are mediated by increasing of PTEN expression levels due to peroxisome proliferator-activated receptor \u03b3 activation. Bull. Korean Chem. Soc. 2012;33(7):2219\u20132223. doi: 10.5012/bkcs.2012.33.7.2219.", "ArticleIdList": ["10.5012/bkcs.2012.33.7.2219"]}, {"Citation": "Yu M.S. Identification of myricetin and scutellarein as novel chemical inhibitors of the SARS coronavirus helicase, nsP13. Bioorg. Med. Chem. Lett. 2012;22:4049\u20134054. doi: 10.1016/j.bmcl.2012.04.081.", "ArticleIdList": ["10.1016/j.bmcl.2012.04.081", "PMC7127438", "22578462"]}, {"Citation": "Semwal D. Myricetin: a dietary molecule with diverse biological activities. Nutrients. 2016;8(2):90. doi: 10.3390/nu8020090.", "ArticleIdList": ["10.3390/nu8020090", "PMC4772053", "26891321"]}, {"Citation": "Chan Interactions between traditional Chinese medicines and Western therapeutics. Curr. Opin. Drug Discov. Devel. 2010;13(1):50\u201365.", "ArticleIdList": ["20047146"]}, {"Citation": "Hyman B.T. Alzheimer\u2019s disease: cell - specific pathology isolates the hippocampal formation. Science. 1984;225:1168\u20131170. doi: 10.1126/science.6474172.", "ArticleIdList": ["10.1126/science.6474172", "6474172"]}, {"Citation": "Ye C. The natural compound myricetin effectively represses the malignant progression of prostate Cancer by inhibiting PIM1 and disrupting the PIM1/CXCR4 interaction. Cell. Physiol. Biochem. 2018;48:1230\u20131244. doi: 10.1159/000492009.", "ArticleIdList": ["10.1159/000492009", "30045021"]}, {"Citation": "Qing Zh. Scutellaria baicalensis, the golden herb from the garden of Chinese medicinal plants. Science bulletin. 2016;61(18):1391\u20131398. doi: 10.1007/s11434-016-1136-5.", "ArticleIdList": ["10.1007/s11434-016-1136-5", "PMC5031759", "27730005"]}, {"Citation": "Chen F. In vitro susceptibility of 10 clinical isolates of SARS coronavirus to selected antiviral compounds. J. clin. Virol. off. Pub. Pan American Soc. Clin. Virol. 2004;31(1):69\u201375. doi: 10.1016/j.jcv.2004.03.003.", "ArticleIdList": ["10.1016/j.jcv.2004.03.003", "PMC7128415", "15288617"]}, {"Citation": "Liu Hongbo. 2020. Scutellaria Baicalensis Extract and Baicalein Inhibit Replication of SARS-CoV-2 and its 3C-like Protease in Vitro.", "ArticleIdList": ["10.1101/2020.04.10.035824", "PMC7850424", "33491508"]}, {"Citation": "Xu X. Baicalin induces human mucoepidermoid carcinoma Mc3 cells apoptosis in vitro and in vivo. Invest. New Drugs. 2011;29:637\u2013645. doi: 10.1007/s10637-010-9402-x.", "ArticleIdList": ["10.1007/s10637-010-9402-x", "20204673"]}, {"Citation": "Chen C.N. Inhibition of SARS-CoV 3C-like protease activity by Theaflavin-3,3-digallate (TF3) Evid. Based Complement. Altern. Med. 2005;2:209\u2013215. doi: 10.1093/ecam/neh081.", "ArticleIdList": ["10.1093/ecam/neh081", "PMC1142193", "15937562"]}, {"Citation": "Clark K.J. An in vitro study of theaflavins extracted from black tea to neutralize bovine rotavirus and bovine coronavirus infections. Vet. Microbiol. 1998;63:147\u2013157. doi: 10.1016/S0378-1135(98)00242-9.", "ArticleIdList": ["10.1016/S0378-1135(98)00242-9", "PMC7117136", "9850995"]}, {"Citation": "Park J.-Y. Evaluation of polyphenols from Broussonetia papyrifera as coronavirus protease inhibitors. J. Enzyme Inhib. Med. Chem. 2017;32(1):504\u2013512. doi: 10.1080/14756366.2016.1265519.", "ArticleIdList": ["10.1080/14756366.2016.1265519", "PMC6010046", "28112000"]}, {"Citation": "Paraiso I.L. Potential use of polyphenols in the battle against COVID-19. Curr. Opin. Food Sci. 2020 doi: 10.1016/j.cofs.2020.08.004.", "ArticleIdList": ["10.1016/j.cofs.2020.08.004", "PMC7480644", "32923374"]}, {"Citation": "Anon herba Houttuynia. Modern Study Trad. Chinese Med. 1997;3:2983\u20133003."}, {"Citation": "Thiel Mechanisms and enzymes involved in SARS coronavirus genome expression. J. Gen. Virol. 2003;84:2305\u20132315. doi: 10.1099/vir.0.19424-0.", "ArticleIdList": ["10.1099/vir.0.19424-0", "12917450"]}, {"Citation": "Lau K.M. Immunomodulatory and anti\u2010SARS activities of Houttuynia cordata. J. Ethnopharmacol. 2008;118:79\u201385. doi: 10.1016/j.jep.2008.03.018.", "ArticleIdList": ["10.1016/j.jep.2008.03.018", "PMC7126383", "18479853"]}, {"Citation": "Park J.-Y. Tanshinones as selective and slow-binding inhibitors for SARS-CoV cysteine proteases. Bioorg. Med. Chem. 2012;20:5928\u20135935. doi: 10.1016/j.bmc.2012.07.038.", "ArticleIdList": ["10.1016/j.bmc.2012.07.038", "PMC7127169", "22884354"]}, {"Citation": "Park J.-Y. Chalcones isolated from Angelica keiskei inhibit cysteine proteases of SARS-CoV. J. Enzyme Inhib. Med. Chem. 2016;31(1):23\u201330. doi: 10.3109/14756366.2014.1003215.", "ArticleIdList": ["10.3109/14756366.2014.1003215", "25683083"]}, {"Citation": "Chang F.R. Anti-Human Coronavirus (anti-HCoV) triterpenoids from the leaves of Euphorbia neriifolia. Nat. Prod. Commun. 2012;7:1\u20133. doi: 10.1177/1934578X1200701103.", "ArticleIdList": ["10.1177/1934578X1200701103", "23285797"]}, {"Citation": "Cinatl J. Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus. Lancet. 2003;361:2045\u20132059.", "ArticleIdList": ["PMC7112442", "12814717"]}, {"Citation": "Guinea M.C. Biologically active triterpene saponins from Bupleurum fruticosum. Planta Med. 1994;60:163\u2013167. doi: 10.1055/s-2006-959442.", "ArticleIdList": ["10.1055/s-2006-959442", "8202567"]}, {"Citation": "Recio M.C. Anti-in\ufb02ammatory activity of Saikosaponins from Heteromorpha trifoliate. J. Nat. Prod. 1995;58:140\u2013144. doi: 10.1021/np50115a023.", "ArticleIdList": ["10.1021/np50115a023", "7760072"]}, {"Citation": "Bermejo Benito P. In vivo and in vitro anti-in\ufb02ammatory activity of Saikosaponins. Life Sci. 1998;63:1147\u20131156. doi: 10.1016/S0024-3205(98)00376-2.", "ArticleIdList": ["10.1016/S0024-3205(98)00376-2", "9763210"]}, {"Citation": "Cheng P.W. Antiviral effects of Saikosaponins on human coronavirus 229E in vitro. Clin. Exp. Pharmacol. Physiol. 2006;33:612\u2013616. doi: 10.1111/j.1440-1681.2006.04415.x.", "ArticleIdList": ["10.1111/j.1440-1681.2006.04415.x", "PMC7162031", "16789928"]}, {"Citation": "Wen Specific plant terpenoids and lignoids possess potent antiviral activities against severe acute respiratory syndrome coronavirus. J. Med. Chem. 2007;50:4087\u20134095. doi: 10.1021/jm070295s.", "ArticleIdList": ["10.1021/jm070295s", "17663539"]}, {"Citation": "Yang H. The crystal structures of severe acute respiratory syndrome virus main protease and its complex with an inhibitor. PNAS. 2003;100(23):13190\u201313195. doi: 10.1073/pnas.1835675100.", "ArticleIdList": ["10.1073/pnas.1835675100", "PMC263746", "14585926"]}, {"Citation": "Park J.-Y. Diarylheptanoids from Alnus japonica inhibit papain-like protease of severe acute respiratory syndrome coronavirus. Biol. Pharm. Bull. 2012;35(11):2036\u20132042. doi: 10.1248/bpb.b12-00623.", "ArticleIdList": ["10.1248/bpb.b12-00623", "22971649"]}, {"Citation": "Ho T.Y. Emodin blocks the SARS coronavirus spike protein and angiotensin-converting enzyme 2 interaction. Antiviral Res. 2007;74:92\u2013101. doi: 10.1016/j.antiviral.2006.04.014.", "ArticleIdList": ["10.1016/j.antiviral.2006.04.014", "PMC7114332", "16730806"]}, {"Citation": "Zhang X.W., Yap Y.L. Old drugs as lead compounds for a new disease? Binding analysis of SARS coronavirus main proteinase with HIV, psychotic and parasite drugs. Bioorg. Med. Chem. 2004;12(10):2517\u20132521. doi: 10.1016/j.bmc.2004.03.035.", "ArticleIdList": ["10.1016/j.bmc.2004.03.035", "PMC7126105", "15110833"]}, {"Citation": "Kiplin G. Rapid repurposing of drugs for COVID-19. Science. 2020;368(6493):829\u2013830. doi: 10.1126/science.abb9332.", "ArticleIdList": ["10.1126/science.abb9332", "32385101"]}, {"Citation": "Riva Laura. A large-scale drug repositioning survey for SARS-CoV-2. Antivirals. 2020 doi: 10.1101/2020.04.16.044016.", "ArticleIdList": ["10.1101/2020.04.16.044016"]}, {"Citation": "Amaro Rommie E., Adrian Mulholland J. A community letter regarding sharing biomolecular simulation data for COVID-19. J. Chem. Inf. Model. 2020;60(6):2653\u20132656. doi: 10.1021/acs.jcim.0c00319.", "ArticleIdList": ["10.1021/acs.jcim.0c00319", "32255648"]}, {"Citation": "https://clinicaltrials.gov/ct2/show/NCT04377789?cond=COVID-19&draw=14, accessed on 06/13/2020."}, {"Citation": "https://clinicaltrials.gov/ct2/show/NCT04377789?cond=COVID-19&draw=3&rank=184, accessed on 05/15/2020."}, {"Citation": "https://clinicaltrials.gov/ct2/show/NCT04375202?cond=COVID-19&draw=2&rank=61, accessed on 05/15/2020."}, {"Citation": "https://clinicaltrials.gov/ct2/show/NCT04308317?cond=COVID-19&draw=4&rank=298, accessed on 05/15/2020."}, {"Citation": "https://clinicaltrials.gov/ct2/show/NCT04333550?cond=COVID-19&draw=5&rank=3, accessed on 05/15/2020."}, {"Citation": "https://clinicaltrials.gov/ct2/show/NCT04359316?cond=COVID-19&draw=2&rank=78, accessed on 05/15/2020."}, {"Citation": "https://clinicaltrials.gov/ct2/show/NCT04344444?cond=COVID-19&draw=4&rank=244, accessed on 05/15/2020."}, {"Citation": "https://clinicaltrials.gov/ct2/show/NCT04332094?cond=COVID-19&draw=4&rank=273, accessed on 05/15/2020."}, {"Citation": "Porter J.B. A risk-benefit assessment of iron-chelation therapy. DrugSafety. 1997;17:407\u2013421. doi: 10.2165/00002018-199717060-00006.", "ArticleIdList": ["10.2165/00002018-199717060-00006", "9429839"]}, {"Citation": "Mortazavi M., Akbarzadeh A. Improvement of desferrioxamine B production of Streptomyces pilosus ATCC 19797 with use of protease inhibitor and minerals related to its activity. Indian J. Clin. Biochem. 2012;27(3):274\u2013277.", "ArticleIdList": ["PMC4577503", "26405387"]}, {"Citation": "Georgiou N.A. Inhibition of human immunodeficiency virus type 1 replication in human mononuclear blood cells by the iron chelators deferoxamine, deferiprone, and bleomycin. J. Infect. Dis. 2000;181(2):484\u2013490. doi: 10.1016/j.antiviral.2004.03.003.", "ArticleIdList": ["10.1016/j.antiviral.2004.03.003", "10669330"]}, {"Citation": "Naesens Role of human hypoxanthine guanine phosphoribosyl transferase in activation of the antiviral agent T-705 (favipiravir) Mol. Pharmacol. 2013;84:615\u2013629. doi: 10.1124/mol.113.087247.", "ArticleIdList": ["10.1124/mol.113.087247", "23907213"]}, {"Citation": "Takahashi In vitro and in vivo activities of T-705 and oseltamivir against influenza virus. Antivir. Chem. Chemother. 2003;14:235\u2013241. doi: 10.1177/095632020301400502.", "ArticleIdList": ["10.1177/095632020301400502", "14694986"]}, {"Citation": "Tanaka T. T-705 (Favipiravir) suppresses tumor necrosis factor \u03b1 production in response to influenza virus infection: a beneficial feature of T-705 as an anti-influenza drug. Acta Virol. 2017;61(1):48\u201355. doi: 10.4149/av_2017_01_48.", "ArticleIdList": ["10.4149/av_2017_01_48", "28105854"]}, {"Citation": "Furuta Favipiravir (T-705), a novel viral RNA polymerase inhibitor. Antiviral Res. 2013;100(2):446\u2013454. doi: 10.1016/j.antiviral.2013.09.015\\.", "ArticleIdList": ["10.1016/j.antiviral.2013.09.015\\", "PMC3880838", "24084488"]}, {"Citation": "Shiraki K., Daikoku T. Favipiravir, an anti-influenza drug against life-threatening RNA virus infections. Pharmacol. Ther. 2020;209 doi: 10.1016/j.pharmthera.2020.107512.", "ArticleIdList": ["10.1016/j.pharmthera.2020.107512", "PMC7102570", "32097670"]}, {"Citation": "Robert A., Terkeltaub M.D. Colchicine Update: 2008. Semin. Arthritis Rheum. 2009;38(6):411\u2013419. doi: 10.1016/j.semarthrit.2008.08.006.", "ArticleIdList": ["10.1016/j.semarthrit.2008.08.006", "18973929"]}, {"Citation": "Newman D.J. The influence of natural products upon drug discovery. Nat. Prod. Rep. 2000;17:215\u2013234. doi: 10.1039/a902202c.", "ArticleIdList": ["10.1039/a902202c", "10888010"]}]}], "History": [{"Year": "2020", "Month": "7", "Day": "15"}, {"Year": "2020", "Month": "10", "Day": "1"}, {"Year": "2020", "Month": "10", "Day": "5"}, {"Year": "2020", "Month": "10", "Day": "15", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "10", "Day": "15", "Hour": "6", "Minute": "1"}, {"Year": "2020", "Month": "10", "Day": "14", "Hour": "12", "Minute": "44"}, {"Year": "2020", "Month": "10", "Day": "8"}], "PublicationStatus": "ppublish", "ArticleIdList": ["33052305", "PMC7543902", "10.1016/j.cpb.2020.100180", "S2214-6628(20)30061-X"]}}]}